EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Relevance of Extending FGFR3 Gene Analysis in Osteochondrodysplasia to Non-Coding Sequences: A Case Report

Zangbéwendé Guy Ouedraogo iD, Caroline Janel, Alexandre Janin, Gilles Millat iD, Sarah Langlais, Bénédicte Pontier, Marie Biard, Mathis Lepage, Christine Francannet, Fanny Laffargue, Isabelle Creveaux iD

Genes · 2024

DOI: 10.3390/genes15020225 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Genes, 2024. Verfasst von Zangbéwendé Guy Ouedraogo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Service de Biochimie et Génétique Moléculaire, CHU Gabriel Montpied, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France. Hauptthemen laut MEDLINE: Osteochondrodysplasias, Achondroplasia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: La Direction de la Recherche Clinique et de l’Innovation (DRCI), CHU Clermont-Ferrand, France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skeletal dysplasia, also called osteochondrodysplasia, is a category of disorders affecting bone development and children’s growth. Up to 552 genes, including fibroblast growth factor receptor 3 (FGFR3), have been implicated by pathogenic variations in its genesis. Frequently identified causal mutations in osteochondrodysplasia arise in the coding sequences of the FGFR3 gene: c.1138G>A and c.1138G>C in achondroplasia and c.1620C>A and c.1620C>G in hypochondroplasia. However, in some cases, the diagnostic investigations undertaken thus far have failed to identify the causal anomaly, which strengthens the relevance of the diagnostic strategies being further refined. We observed a Caucasian adult with clinical and radiographic features of achondroplasia, with no common pathogenic variant. Exome sequencing detected an FGFR3(NM_000142.4):c.1075+95C>G heterozygous intronic variation. In vitro studies showed that this variant results in the aberrant exonization of a 90-nucleotide 5′ segment of intron 8, resulting in the substitution of the alanine (Ala359) for a glycine (Gly) and the in-frame insertion of 30 amino acids. This change may alter FGFR3’s function. Our report provides the first clinical description of an adult carrying this variant, which completes the phenotype description previously provided in children and confirms the recurrence, the autosomal-dominant pathogenicity, and the diagnostic relevance of this FGFR3 intronic variant. We support its inclusion in routinely used diagnostic tests for osteochondrodysplasia. This may increase the detection rate of causal variants and therefore could have a positive impact on patient management. Finally, FGFR3 alteration via non-coding sequence exonization should be considered a recurrent disease mechanism to be taken into account for new drug design and clinical trial strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteochondrodysplasiasAchondroplasiaChildAdultHumansMutationExonsPhenotypeReceptor, Fibroblast Growth Factor, Type 3

Stichwörter der Autor:innen

achondroplasiaexonizationfibroblast growth factor receptor 3hypochondroplasiaosteochondrodysplasiaskeletal dysplasia

Substanzen

FGFR3 protein, humanReceptor, Fibroblast Growth Factor, Type 3

Autor:innen und Institutionen

  • Service de Biochimie et Génétique Moléculaire, CHU Gabriel Montpied, CHU Clermont-Ferrand, 63000 Clermont-Ferrand, France.
  • Université Clermont Auvergne, CNRS, Inserm, iGReD, 63001 Clermont-Ferrand, France.
  • Unité Fonctionnelle Cardiogénétique, Moléculaire, Centre de Biologie et Pathologie Est, Hospices Civils de Lyon, 69677 Bron, France.
  • CNRS UMR5261, INSERM U1315, Pathophysiology and Genetics of Neuron and Muscle, Institut Neuromyogène, Université Claude Bernard Lyon 1, 69008 Lyon, France.
  • Service de Génétique Médicale, CHU Estaing, CHU Clermont-Ferrand, 63100 Clermont-Ferrand, France.
  • Service de Radiologie Pédiatrique, CHU Estaing, CHU Clermont-Ferrand, 63100 Clermont-Ferrand, France.

ORCID-Profile: Zangbéwendé Guy Ouedraogo, Gilles Millat, Isabelle Creveaux

Förderung

  • La Direction de la Recherche Clinique et de l’Innovation (DRCI), CHU Clermont-Ferrand, France

Zitieren

APA

Ouedraogo, Z. G., Janel, C., Janin, A., Millat, G., Langlais, S., Pontier, B., Biard, M., Lepage, M., Francannet, C., Laffargue, F., & Creveaux, I. (2024). Relevance of Extending FGFR3 Gene Analysis in Osteochondrodysplasia to Non-Coding Sequences: A Case Report. Genes. https://doi.org/10.3390/genes15020225

Vancouver

Ouedraogo ZG, Janel C, Janin A, Millat G, Langlais S, Pontier B, et al. Relevance of Extending FGFR3 Gene Analysis in Osteochondrodysplasia to Non-Coding Sequences: A Case Report. Genes. 2024. doi:10.3390/genes15020225

BibTeX
@article{Ouedraogo2024,
  author = {Ouedraogo, Zangbéwendé Guy and Janel, Caroline and Janin, Alexandre and Millat, Gilles and Langlais, Sarah and Pontier, Bénédicte and Biard, Marie and Lepage, Mathis and Francannet, Christine and Laffargue, Fanny and Creveaux, Isabelle},
  title = {Relevance of Extending FGFR3 Gene Analysis in Osteochondrodysplasia to Non-Coding Sequences: A Case Report},
  journal = {Genes},
  year = {2024},
  doi = {10.3390/genes15020225}
}
Kostenlos starten →